Akebia Therapeutics (AKBA) FCF Margin (2017 - 2026)
Akebia Therapeutics (AKBA) recorded FCF Margin of 4.98% in Q2 2026, down 30.59 percentage points from 35.57% a year earlier but up 44.70 percentage points from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) FCF Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Akebia Therapeutics' FCF Margin came in at 18.38% as of Jun 30, 2026, up 19.63 percentage points year-over-year; for FY2025, it came in at 28.66%, up 54.07 percentage points from FY2024.
- Annual FCF Margin has a five-year change of +66.24 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -25.40% in FY2024 (-13.39 pp), -12.02% in FY2023 (+13.04 pp), -25.05% in FY2022 (+94.50 pp) and -119.55% in FY2021 (-81.98 pp).
- Quarterly FCF Margin has ranged from -115.41% in Q3 2021 to 69.39% in Q3 2022 over the past five years.
- On a year-over-year basis, FCF Margin rose in four of the last eight quarters, with an average year-over-year change of +21.34 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 184.81 percentage points in Q3 2022, against a drop of 86.44 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -39.72% (Q1 2026), 53.90% (Q4 2025) and 47.69% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | 4.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.98% |
| Mar 31, 2026 | -39.72% |
| Dec 31, 2025 | 53.90% |
| Sep 30, 2025 | 47.69% |
| Jun 30, 2025 | 35.57% |
| Mar 31, 2025 | -23.73% |
| Dec 31, 2024 | -9.61% |
| Sep 30, 2024 | -17.89% |
| Jun 30, 2024 | -23.13% |
| Mar 31, 2024 | -59.59% |
| Dec 31, 2023 | -4.11% |
| Sep 30, 2023 | -17.05% |
| Jun 30, 2023 | 6.44% |
| Mar 31, 2023 | -43.84% |
| Dec 31, 2022 | -98.02% |
| Sep 30, 2022 | 69.39% |
| Jun 30, 2022 | -24.26% |
| Mar 31, 2022 | -35.23% |
| Dec 31, 2021 | -108.90% |
| Sep 30, 2021 | -115.41% |
API Access
Akebia Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();